BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7429322)

  • 1. Rectal mucosal prostaglandin E2 release and its relation to disease activity, electrical potential difference, and treatment in ulcerative colitis.
    Rampton DS; Sladen GE; Youlten LJ
    Gut; 1980 Jul; 21(7):591-6. PubMed ID: 7429322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between rectal mucosal prostaglandin production and water and electrolyte transport in ulcerative colitis.
    Rampton DS; Sladen GE
    Digestion; 1984; 30(1):13-22. PubMed ID: 6149163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sulphasalazine withdrawal on rectal mucosal function and prostaglandin E2 release in inactive ulcerative colitis.
    Rampton DS; Sladen GE
    Scand J Gastroenterol; 1981; 16(1):157-9. PubMed ID: 6112788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin synthesis inhibitors in ulcerative colitis: flurbiprofen compared with conventional treatment.
    Rampton DS; Sladen GE
    Prostaglandins; 1981 Mar; 21(3):417-25. PubMed ID: 6112777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal mucosal histamine release in ulcerative colitis.
    Rampton DS; Murdoch RD; Sladen GE
    Clin Sci (Lond); 1980 Nov; 59(5):389-91. PubMed ID: 6159132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of topical 5-aminosalicylic acid and prednisolone on prostaglandin E2 and leukotriene B4 levels determined by equilibrium in vivo dialysis of rectum in relapsing ulcerative colitis.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gastroenterology; 1986 Oct; 91(4):837-44. PubMed ID: 3017804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.
    Lauritsen K; Hansen J; Bytzer P; Bukhave K; Rask-Madsen J
    Gut; 1984 Nov; 25(11):1271-8. PubMed ID: 6149981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are prostaglandins cytoprotective in the human large intestine? The effect of indomethacin on rectal mucosal function and prostaglandin E2 release in vivo.
    Rampton DS; Barton TP
    Agents Actions; 1984 Jun; 14(5-6):715-8. PubMed ID: 6591772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine.
    Sharon P; Ligumsky M; Rachmilewitz D; Zor U
    Gastroenterology; 1978 Oct; 75(4):638-40. PubMed ID: 30669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rectal mucosal prostaglandin E release and electrolyte transport in ulcerative colitis.
    Rampton DS; Sladen GE; Bhakoo KK; Heinzelmann DI; Youlten LJ
    Adv Prostaglandin Thromboxane Res; 1980; 8():1621-5. PubMed ID: 7377010
    [No Abstract]   [Full Text] [Related]  

  • 11. Verapamil inhibits in-vitro leucotriene B4 release by rectal mucosa in active ulcerative colitis.
    Gertner DJ; Rampton DS; Stevens TR; Lennard-Jones JE
    Aliment Pharmacol Ther; 1992 Apr; 6(2):163-8. PubMed ID: 1318088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper.
    Carty E; De Brabander M; Feakins RM; Rampton DS
    Gut; 2000 Apr; 46(4):487-92. PubMed ID: 10716677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal and plasma prostaglandin E2 in ulcerative colitis.
    Wiercinska-Drapalo A; Flisiak R; Prokopowicz D
    Hepatogastroenterology; 1999; 46(28):2338-42. PubMed ID: 10521993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and mucosal prostaglandin E2 as a surrogate marker of ulcerative colitis activity.
    Wiercińska-Drapało A; Flisiak R; Prokopowicz D
    Rocz Akad Med Bialymst; 2001; 46():60-8. PubMed ID: 11780581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
    Raab Y; Sundberg C; Hällgren R; Knutson L; Gerdin B
    Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ulcerative colitis activity on plasma and mucosal prostaglandin E2 concentration.
    Wiercińska-Drapało A; Flisiak R; Prokopowicz D
    Prostaglandins Other Lipid Mediat; 1999 Oct; 58(2-4):159-65. PubMed ID: 10560618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anorectal contractility under basal conditions and during rectal infusion of saline in ulcerative colitis.
    Rao SS; Read NW; Stobart JA; Haynes WG; Benjamin S; Holdsworth CD
    Gut; 1988 Jun; 29(6):769-77. PubMed ID: 3384361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of prednisolone on prostaglandin synthesis by rectal mucosa in ulcerative colitis: investigation by laminar flow bioassay and radioimmunoassay.
    Hawkey CJ; Truelove SC
    Gut; 1981 Mar; 22(3):190-3. PubMed ID: 7227851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does vitamin E supplementation modulate in vivo arachidonate metabolism in human inflammation?
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Pharmacol Toxicol; 1987 Oct; 61(4):246-9. PubMed ID: 2829153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo profiles of eicosanoids in ulcerative colitis, Crohn's colitis, and Clostridium difficile colitis.
    Lauritsen K; Laursen LS; Bukhave K; Rask-Madsen J
    Gastroenterology; 1988 Jul; 95(1):11-7. PubMed ID: 2836256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.